A Study on the Clinical Course and Antimicrobial Susceptibility of <i>Mycoplasma pneumoniae </i>in a Community Hospital
Takahiro Sakai(Japanese Red Cross Society, Japan), Keigo Shibayama(National Institute of Infectious Diseases), Hiroshige Yoshioka(Harbin Medical University), Kenjiro Furuta(Kurashiki Central Hospital), Tsuyoshi Kenri(National Institute of Infectious Diseases), Tadasi ISHIDA(Kurashiki Central Hospital), Hiroshi Nakajima(Okayama University), Akihiro Ito(Hiroshima University), Maki Noyama(Kurashiki Central Hospital), Toru Hashimoto(Kyushu University), Hiroyuki Fujii(Fukuoka Higashi Medical Center), Hiromasa Tachibana(Kyoto Medical Center), Akihiro Nishiyama(Kurashiki Central Hospital), Machiko Arita(Kurashiki Central Hospital), Fumiaki Tokioka(Kurashiki Central Hospital)
Cited by 1
Related Papers
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC
|New England Journal of Medicine|2024|369
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
|Annals of Oncology|2017|294
Aryne-based strategy in the total synthesis of naturally occurring polycyclic compounds
|Chemical Society Reviews|2018|293
Some Properties of the Products of Reaction of Tadpole Collagenase with Collagen<sup>*</sup>
|Biochemistry|1967|246
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
|Journal of Clinical Oncology|2016|160